Next, when the aggregated patient population from the GBM dataset was dichotomized into those who expressed more GLUT1 than the sample median and those who expressed less GLUT1 than the median, the high-GLUT1 group demonstrated worse survivorship (Figure 1B). The gene discussed is SLC2A1; the disease is glioblastoma.